Authors
Latest:
Focus on the Medical Benefit: A Manufacturer's PerspectiveAs more specialty pharmaceuticals products continue to come to the market, the manufacturer's goal should be to understand what will impact payer coverage.
Latest:
EntrestoEntresto is a combination of a first-in-class neprilysin inhibitor and an angiotensin receptor blocker indicated for the treatment of heart failure with reduced ejection fraction.
Latest:
The Application of Drug-Dosing Guidelines Based on Preemptive Genetic TestingThe application of genetic data to effectively influence health care outcomes is poised for rapid acceptance. Genetic testing can provide results that can be used to make the best therapeutic choices.
Latest:
How Pharmacists Can Help Patients Save MoneyMedication is not cheap, but we can help ensure that cost is not a barrier to adherence. Here are some tips.
Latest:
McCurdy Advances the Profession of Pharmacy Through Strong Community SpiritThis month's RESPy winner, UCSF School of Pharmacy's Megan McCurdy, is a true champion of community volunteerism and advancing the pharmacy profession.
Latest:
A Population-Based Approach to Improving Patient Safety Related to Drug—Drug InteractionsSome medication combinations are a source of preventable drug-related harm. A multifaceted approach is needed to address this quality-of-care issue.
Latest:
Bispecific Antibodies: The Next Generation of ImmunotherapyAdvances in biotechnology have improved the production and recombination of antibodies, leading to improvements in monoclonal antibody therapies.
Latest:
Rare Pharmacy Emerges From Specialty, Part 2Challenges and impact of rare diseases are faced by pharmacy stakeholders.
Latest:
Initiating an Antimicrobial Stewardship Program: The Costs and the BenefitsFor decades, our growing and reliable arsenal of antibiotic and antimicrobial drugs created a dangerously cavalier attitude toward the nature of microbial pathogens and the true threat to public health they represent.
Latest:
Findings Related to Assessing Value for Private US Health PlansA qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.
Latest:
The Impending Patent Cliff: Implications for PharmacistsAs blockbuster drugs begin losing patent protection, pharmaceutical companies and pharmacists will address key marketplace changes.
Latest:
Specialty Pharmacy: Making a DifferenceWe welcome our new editorial advisory board member, a leader and innovator in the industry.
Latest:
Examining New Treatment Strategies Aimed at Stroke Prevention in Patients with Atrial Fibrillation: A Multidisciplinary DiscussionPharmacists can learn about educating patients on the risk of stroke in atrial fibrillation, monitoring anticoagulation therapy, and participating in disease management opportunities.
Latest:
Pharmacist In Action: Pandemic Delivers Student a Unique RotationBen Harding, a P4 student, discusses the scenario of being a pharmacy student during the COVID-19 pandemic.
Latest:
Hypertension: Revealing the Silent KillerHypertension is a leading modifiable risk factor for heart disease and stroke.
Latest:
Generic Drug Trends-What's Next?Big changes are coming in the generic marketplace worldwide in the coming decade.
Latest:
Case Studies (January 2020)What could be causing this patient's involuntary, repetitive movements in her arms and legs?
Latest:
Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis TreatmentThe authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.
Latest:
Economic Model Comparing Rivaroxaban and Enoxaparin for Post-Orthopedic VTE ProphylaxisThis analysis evaluates-from a US payer's perspective-the economic impact of using rivaroxaban versus enoxaparin for thromboprophylaxis following total hip or knee replacement surgery.
Latest:
Trends That Will Affect Specialty Health Care Into the FutureÂCurrent developments and innovations that will shape the future of specialty pharmacy.
Latest:
The Benefits of the Hub for Specialty PatientsPharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
